In situ monitoring of bindings between dasatinib and its target protein kinases using magnetic nanoparticles in live cells.
Kim
Dae-Joong
DJ
CGK Co., Ltd., Daejeon Bioventure Town, 461-8, Jeonmin-Dong, Yuseong-Gu, Daejeon, 305-811, Korea.
Yi
Yong-Weon
YW
Kim
Jin Hwan
JH
D002470:Cell Survival; D000069439:Dasatinib; D006367:HeLa Cells; D006801:Humans; D008280:Magnetics; D053758:Nanoparticles; D011485:Protein Binding; D047428:Protein Kinase Inhibitors / Q000378:metabolism*; D011494:Protein Kinases / Q000378:metabolism*; D011743:Pyrimidines / Q000378:metabolism*; D013844:Thiazoles / Q000378:metabolism*
D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D013844:Thiazoles; D011494:Protein Kinases; D000069439:Dasatinib